摘要
目的探讨肾炎清片对无症状性血尿患者IL-6和VEGF水平的影响。方法将76例临床诊断为无症状性血尿患者随机分为治疗组和对照组各38例,对照分析肾炎清片治疗前和治疗后无症状血尿患者的IL-6和VEGF的水平。结果肾炎清片治疗组无症状生血尿患者的IL6和VEGF的水平较对照组明显降低,结果显示组间的差异具有统计学意义(P<0.05)。结论肾炎清片能够改变无症状性血尿患者IL-6和VEGF的水平,可能对无症状性血尿患者血尿症状的改善具有一定的作用。
Objective To explore the influence of Shenyanqing Tablet on serum IL-6 and VEGF levels in patients with asymptomatic hematuria. Methods 76 cases of renal hematuria patients diagnosed by renal biopsy were randomly divided into treatment group and control group（ n = 38 in each group）. The serum levels of IL-6 and VEGF before and after treatment by Shenyanqing Tablet in patients with asymptomatic hematuria were detected. Results The serum levels of IL-6 and VEGF in treatment group were significantly lower than that of control group（P 〈 0.05 ）. Conclusion Shenyanqing Tablet could change the serum levels of IL-6 and VEGF in patients with asymptomatichematuria, and it may have a certain effect on the improvement of hematuria symptom in the patients with asymptomatic hematuria.
出处
《标记免疫分析与临床》
CAS
2014年第6期688-690,共3页
Labeled Immunoassays and Clinical Medicine
